These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33999013)

  • 21. Molecular and Pathological Features of Gastric Cancer in Lynch Syndrome and Familial Adenomatous Polyposis.
    Fornasarig M; Magris R; De Re V; Bidoli E; Canzonieri V; Maiero S; Viel A; Cannizzaro R
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of chromoendoscopy for surveillance of the duodenum in patients with MUTYH-associated polyposis and familial adenomatous polyposis.
    Hurley JJ; Thomas LE; Walton SJ; Thomas-Gibson S; Haycock A; Suzuki N; Mort M; Williams G; Morgan M; Clark SK; Sampson JR; Dolwani S
    Gastrointest Endosc; 2018 Oct; 88(4):665-673. PubMed ID: 29702101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathology and genetics of hereditary colorectal cancer.
    Ma H; Brosens LAA; Offerhaus GJA; Giardiello FM; de Leng WWJ; Montgomery EA
    Pathology; 2018 Jan; 50(1):49-59. PubMed ID: 29169633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel mutations and phenotypic associations identified through APC, MUTYH, NTHL1, POLD1, POLE gene analysis in Indian Familial Adenomatous Polyposis cohort.
    Khan N; Lipsa A; Arunachal G; Ramadwar M; Sarin R
    Sci Rep; 2017 May; 7(1):2214. PubMed ID: 28533537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synonymous mutation adenomatous polyposis coliΔ486s affects exon splicing and may predispose patients to adenomatous polyposis coli/mutY DNA glycosylase mutation‑negative familial adenomatous polyposis.
    Liu WQ; Dong J; Peng YX; Li WL; Yang J
    Mol Med Rep; 2018 Dec; 18(6):4931-4939. PubMed ID: 30272267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relative role of APC and MUTYH mutations in the pathogenesis of familial adenomatous polyposis.
    Pezzi A; Roncucci L; Benatti P; Sassatelli R; Varesco L; Di Gregorio C; Venesio T; Pedroni M; Maffei S; Reggiani Bonetti L; Borsi E; Ferrari M; Martella P; Rossi G; Ponz De Leon M
    Scand J Gastroenterol; 2009; 44(9):1092-100. PubMed ID: 19593690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. APC or MUTYH mutations account for the majority of clinically well-characterized families with FAP and AFAP phenotype and patients with more than 30 adenomas.
    Filipe B; Baltazar C; Albuquerque C; Fragoso S; Lage P; Vitoriano I; Mão de Ferro S; Claro I; Rodrigues P; Fidalgo P; Chaves P; Cravo M; Nobre Leitão C
    Clin Genet; 2009 Sep; 76(3):242-55. PubMed ID: 19793053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical characterization and mutation spectrum in patients with familial adenomatous polyposis in China.
    Li N; Kang Q; Yang L; Zhao XJ; Xue LJ; Wang X; Li AQ; Li CG; Sheng JQ
    J Gastroenterol Hepatol; 2019 Sep; 34(9):1497-1503. PubMed ID: 31062380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Singapore familial adenomatous polyposis (FAP) patients with classical adenomatous polyposis but undetectable APC mutations have accelerated cancer progression.
    Cao X; Hong Y; Eu KW; Loi C; Cheah PY
    Am J Gastroenterol; 2006 Dec; 101(12):2810-7. PubMed ID: 17026565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Germline mutations of the adenomatous polyposis coli (APC) gene in Algerian familial adenomatous polyposis cohort: first report.
    Khider F; Cherbal F; Boumehdi AL; Layaida K; Mahfouf H; Zebboudj F; Maaoui M
    Mol Biol Rep; 2022 May; 49(5):3823-3837. PubMed ID: 35142982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical characterization and mutation spectrum in Hispanic families with adenomatous polyposis syndromes.
    Cruz-Correa M; Diaz-Algorri Y; Mendez V; Vazquez PJ; Lozada ME; Freyre K; Lathroum L; Gonzalez-Pons M; Hernandez-Marrero J; Giardiello F; Rodriguez-Quilichini S
    Fam Cancer; 2013 Sep; 12(3):555-62. PubMed ID: 23460355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Transcriptomic Landscape of Mismatch Repair-Deficient Intestinal Stem Cells.
    Bommi PV; Bowen CM; Reyes-Uribe L; Wu W; Katayama H; Rocha P; Parra ER; Francisco-Cruz A; Ozcan Z; Tosti E; Willis JA; Wu H; Taggart MW; Burks JK; Lynch PM; Edelmann W; Scheet PA; Wistuba II; Sinha KM; Hanash SM; Vilar E
    Cancer Res; 2021 May; 81(10):2760-2773. PubMed ID: 34003775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resorting the function of the colorectal cancer gatekeeper adenomatous polyposis coli.
    Kariv R; Caspi M; Fliss-Isakov N; Shorer Y; Shor Y; Rosner G; Brazowski E; Beer G; Cohen S; Rosin-Arbesfeld R
    Int J Cancer; 2020 Feb; 146(4):1064-1074. PubMed ID: 31283021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nuclear DNA content of isolated crypts of background colonic mucosa from patients with familial adenomatous polyposis and sporadic colorectal cancer.
    Nakamura S; Kino I; Baba S
    Gut; 1993 Sep; 34(9):1240-4. PubMed ID: 8406162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Colorectal Adenomatous Polyposis: Heterogeneity of Susceptibility Gene Mutations and Phenotypes in a Cohort of Italian Patients.
    Marabelli M; Molinaro V; Abou Khouzam R; Berrino E; Panero M; Balsamo A; Venesio T; Ranzani GN
    Genet Test Mol Biomarkers; 2016 Dec; 20(12):777-785. PubMed ID: 27705013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Barrett's esophagus in the patients with familial adenomatous polyposis.
    Gatalica Z; Chen M; Snyder C; Mittal S; Lynch HT
    Fam Cancer; 2014 Jun; 13(2):213-7. PubMed ID: 23771323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ovarian steroid cell tumor with biallelic adenomatous polyposis coli inactivation in a patient with familial adenomatous polyposis.
    Hu PJ; Knoepp SM; Wu R; Cho KR
    Genes Chromosomes Cancer; 2012 Mar; 51(3):283-9. PubMed ID: 22120905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe polyposis in Apc(1322T) mice is associated with submaximal Wnt signalling and increased expression of the stem cell marker Lgr5.
    Lewis A; Segditsas S; Deheragoda M; Pollard P; Jeffery R; Nye E; Lockstone H; Davis H; Clark S; Stamp G; Poulsom R; Wright N; Tomlinson I
    Gut; 2010 Dec; 59(12):1680-6. PubMed ID: 20926645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A LGR5 reporter pig model closely resembles human intestine for improved study of stem cells in disease.
    Schaaf CR; Polkoff KM; Carter A; Stewart AS; Sheahan B; Freund J; Ginzel J; Snyder JC; Roper J; Piedrahita JA; Gonzalez LM
    FASEB J; 2023 Jun; 37(6):e22975. PubMed ID: 37159340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Foxf2 in intestinal fibroblasts reduces numbers of Lgr5(+) stem cells and adenoma formation by inhibiting Wnt signaling.
    Nik AM; Reyahi A; Pontén F; Carlsson P
    Gastroenterology; 2013 May; 144(5):1001-11. PubMed ID: 23376422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.